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The cAMP system in vasopressin—sensitive nephron segments
of the vitamin D-treated rat
TOMAS BERL
Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA
The cAMP system in vasopressin—sensitive nephron segments of the
vitamin D-treated rat. The present study was undertaken to investigate
the cAMP system in isolated vasopressin (AVP)-sensitive segments of
the hypercalcemic rat. Hypercalcemia was produced by supplementa-
tion of diet with dihydrotachysterol, achieving a mean serum calcium of
12.6 mg%. Maximal urinary concentration was only 1982 119
mOsmlkg H20 in pair, watered hypercalcemic rats when compared to
2478 93 mOsm/kg H20 in controls (N = 7) (P <0.01). Vasopressin
stimulated adenylate cyclase activity at concentrations of vasopressin
between l0 and iO M was indistinguishable in the outer medullary
collecting duct (OMCD) and inner medullary collecting duct (IMCD) of
tubules dissected from hypercalcemic rats or normocalcemic rats.
Likewise, in situ cAMP accumulation in response to l0 M AVP was
not significantly different in either OMCD or IMCD of hypercalcemic or
normocalcemic rats at either isotonic or hypertonic media conditions.
In contrast, while l0- M AVP significantly (P < 0.05) increased cAMP
accumulation in the medullary ascending limb (MAL) of normocalcemic
rats it failed to do so in the MAL of hypercalcemic rats. This failure to
accumulate cAMP appears to be due to impairment in AVP-stimulated
adenylate cyclase rather than to enhanced phosphodiesterase activity.
A similar decrement in glucagon stimulated adenylate cyclase occurred
with 10-6 M glucagon. The results demonstrate that in chronic hyper-
calcemia the cAMP system in the OMCT and IMCD of the rat is intact,
but the MAL demonstrates abnormal AVP responsiveness due to
impaired adenylate cyclase. Such an effect in the MAL may explain the
decreased medullary—solute content in hypercalcemia and thereby
contribute to the concentrating defect seen in the vitamin D treated rat.
The association of hypercalcemia with polyuria and a renal
concentrating defect has been widely recognized in both hu-
mans [1, 21 and experimental animals [3, 4]. Recent studies in
our laboratory have clearly established the nephrogenic nature
of the defect [5]. Furthermore, the concentrating defect and the
polyuria are present in animals even when not allowed to
become polydipsic [5]. The nature of the renal derangement has
also been the subject of intense investigation. On the one hand
there is evidence to support the view that a defect in the
countercurrent multiplier leads to abnormal concentration of
solutes [6, 7], a view supported by the observed decrease in
chloride resorption observed in in vivo loop microperfusion
experiments [8]. On the other hand, a direct cellular effect of
hypercalcemia to decrease the hydroosmotic effect of vasopres-
sin has also been suggested. In this regard, elevation of serosal
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calcium depresses the hydroosmotic response to vasopressin in
the toad bladder [9, 10]; however, no such effect is demonstra-
ble in the cortical collecting duct [11]. Biochemical correlates to
these observations have been made in rat medullary slices [12,
13]. It is now well recognized that vasopressin acts to stimulate
adenylate cyclase in at least two distinct nephron segments, the
collecting duct and the medullary thick ascending limb of
Henle's loop [14]. In the former tubular segment the arginine
vasopressin (AVP)-dependent cAMP system is involved in the
regulation of water and perhaps urea permeability, while in the
ascending limb AVP regulates the transport of sodium chloride
and thereby the concentration of solutes in the interstitium [15].
Studies employing medullary slices cannot differentiate be-
tween these two vasopressin—responsive nephron segments.
Experiments conducted in isolated nephron segments of nor-
mocalcemic animals have examined only the effects of in vitro
acute elevations of calcium in the incubation media [16, 17].
Furthermore, these studies have yielded conflicting results as
one in the rat suggests that a defect in the medullary collecting
duct [16], while another in the mouse points to the medullary
ascending limb as the site of the biochemical defect [17]. In
addition, the pathogenesis of the concentrating defect observed
in chronic hypercalcemia may not be mimicked by such acute
intervention. The present study was designed, therefore, to
study the effects of chronic hypercalcemia on cAMP metabo-
lism in tubular segments that are responsive to vasopressin, that
is, the outer medullary collecting tubule (OMCT), the inner
medullary (papillary) collecting tubules (IMCT) and the medul-
lary thick ascending limb of Henle's loop (MAL). Our results
demonstrate an intact cAMP system in the collecting ducts, but
impaired generation of the nucleotide in the MAL.
Methods
Studies were performed on male Sprague—Dawley rats (Sasco
Inc., Omaha, Nebraska, USA) weighing between 250 and 300 g.
The animals were fed a commercially obtained diet (ICN
Nutritional Biochemicals, Cleveland, Ohio, USA) or an identi-
cal diet to which dihydrotachysterol (Philips Roxan, Columbus,
Ohio, USA) 4.25 mg/kg diet was added. We have previously
demonstrated that such a maneuver promptly increases serum
calcium (by day 3) and remains stable thereafter for another
seven days [5]. Since the ad libitum food intake of rats on a
vitamin D-supplemented diet is somewhat lower than that of
controls, to ensure comparable caloric, protein and mineral
intake, food intake of controls was matched to that of hyper-
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calcemic rats. Likewise, since the water intake of these animals
is higher, their water intake was matched to that of control rats.
At all times the vitamin D-supplemented hypercalcemic rat and
its control were studied together. This was particularly so for
the biochemical studies on the microdissected segments in
which the dissection and the assay in each pair of rats was
performed in the same day so as to minimize the effects of
intraassay variability.
Effect of vitamin D supplementation on serum calcium,
maximal urinary concentration and tissue solute content
Although we have described the abnormalities in water
metabolism that accompany the development of hypercalcemia
in a previous study [51, we again determined the maximal
urinary concentration in the presence of exogenous vasopressin
in seven normocalcemic and seven pair watered rats. Specifi-
cally, after six or seven days on the diet, the rats were placed in
a metabolic cage, water was withdrawn for 24 hours and the
urine was collected over the subsequent six hours. The admin-
istration of 500 mU of antidiuretic hormone in oil subcutane-
ously on the day of dehydration and repeated the next morning
when the urine samples were being obtained ensured maximal
levels of circulating vasopressin.
Following the concentrating test the animals were anesthe-
tized with phenobarbital (6 mg/l00 body wt). Blood for serum
calcium was obtained by aortic puncture and the kidneys were
removed rapidly and placed in an ice bath for determination of
tissue solute employing a modification of the method of Ap-
peibloom et al [181 as previously described from our laboratory
[5, 19]. Briefly, the kidneys were cut along their longitudinal
axis using a razor blade and scalpel. Sections of the cortex,
outer medulla, base and papilla were dissected free, frozen in
liquid nitrogen and immediately weighed. Tissues from one
kidney were then homogenized for determination of sodium,
potassium and urea nitrogen content, while tissues of the
contralateral kidney were dried to constant weight (72 hours)
for determination of tissue water content. Sodium and potas-
sium were determined by atomic absorption spectrophotometer
(Perkins Elmer, Norwalk, Connecticut, USA) while urea nitro-
gen was measured by autoanlyzer (Technicon Instruments
Corp., Tarrytown, New York, USA). The tissue osmolality was
measured from the sodium, potassium and urea contents.
Microdissection of tubules
Rats were lightly anesthetized with pentobarbital (3 mg/l00 g
body wt) and the left kidney was perfused with 10 ml of
collagenase medium [137 m'vi NaCl, 5 m'vi KC1, 0.8 mr'vi MgSO4,
0.33 m'vi Na2HPO4, 1 m'vi MgC12, 0.25 mivi CaCl2, 10 mM
glucose, 10 m Tris, pH 7.4, 20 U/mI collagenase (Millipore
Corp., Freehold, New Jersey, USA), 1 mg/mi hyaluronidase
(Sigma, St. Louis, Missouri, USA), and 1 mg/mI bovine serum
albumin with 20 U/mi heparin] at an infusion rate of 1 mllmin.
The medullary tissue was dissected and sliced to thin strips with
direction from cortex to papillary tip. Then the pieces were
incubated in an aerated collagenase medium for 60 minutes at
35°C. After incubation the tissues were washed with cold
microdissection medium (same as the collagenase medium
except 1 mM CaCI2 and no collagenase, hyaluronidase, and
bovine serum albumin) and kept in ice while microdissection
was performed. Inner medullary collecting ducts (IMCD), outer
medullary collecting ducts (OMCD) and thick medullary as-
cending limb (MAL) were dissected under a stereomicroscope
using thin needles. Dissected tubules were transferred to a
concave bacteriological slide by aspiration in a small droplet of
microdissection medium. The tubule were then photographed
to measure the lengths (1 to 2 mm for adenylate cyclase and
cAMP phosphodiesterase, 3 to 4 mm for cAMP per sample).
The microdissected tubules were studied in the following ways.
Determination of in situ cAMP. The microdissection medium
was aspirated off and 2.5 d of modified Krebs—Ringer buffer
(140 mM NaC1, 5 mrvi KC1, 1.2 mM MgSO4, 10 m glucose, 0.8
mM CaCI2, 10 m sodium acetate, 2 mis NaH2PO4, and 20 mM
Tris-HC1, pH 7.4) without (basal) or with 1 x lO M arginine
vasopressin (AVP). The samples were covered with vase-
line—coated concave slides and were incubated at 30°C for 20
minutes. The incubation was stopped by freezing on dry ice,
then the frozen samples were transferred to 12 x 75 glass tubes.
A buffer of 100 al 50 m sodium acetate, pH 6.2, were added
and boiled for three minutes the samples were stored at —20°C
until assayed. Since media osmolality can itself affect the
generation of cAMP [201, in addition to performing the above
studies at a media concentration of 300 mOsm/kg, we also
assessed the in situ accumulation of cAMP at a media osmolai-
ity that mimics that prevailing in vivo. Thus, the OMCD and
MAL were studied also at 800 mOsmlkg and the IMCD at 2000
mOsm/kg H20. This was accomplished by adding sodium
chloride and urea to the Krebs—Ringer buffer so as to maintain
the 2: 1 ratio of urea and sodium chloride: for 800 mOsm/kg, 197
mM NaC1 and 370 m urea; for 2000 mOsni/kg, 497 m NaC1
and 980 m urea.
Following acetylation of the experimental samples and stan-
dard, cAMP was determined by radioimmunoassay (RIA kit
from New England Nuclear, Boston, Massachusetts, USA). In
all cases niicrodissection and assay of a hypercalcemic and its
normocaicemic control were performed simultaneously. The
assays were performed in four replications. The quadruplicate
determinations were meaned in any given experiment for an
"n" of one. The variability of the replicate samples ranged from
3 to 15%.
Adenylate cyclase activity. The effect of hypercalceniia on
the activity of adenylate cyclase was studied. Following micro-
dissection of the OMCT, IMCT and MAL described above, the
tubules were disrupted (permeabilized) by subjecting them to
hypoosmotic shock and freezing. Specifically, after the micro-
dissection fluid was aspirated off, 0.5 d hypoosmotic medium
(1 mM MgC12, 0.25 mi EDTA, 0.1% bovine serum albumin, and
1 mM Tris, pH 7.4) was added under the microscope; the
samples were then immediately frozen by placing them on a
block of dry ice. The frozen tubules were thawed once and
refrozen, then kept at —80°C until assayed. The basal and
hormone stimulated activities of adenylate cyclase were stable
at —80°C for at least five days.
The activity of adenylate cyclase was measured according to
a modification [21] of the method of Morel, Chabardes and
Imbert—Teboul [221. Slides with original tubular length of ito 2
mm were incubated at 37°C for 30 minutes in a final volume of
5.5 d containing 0.25 m'vi 32P-ATP (4 to 5 x 106 cpm/sample),
1 mM cAMP, 3.8 m MgCI2, 0.25 m EDTA, 20 mri creatine
phosphate, 1 mg/mi creatine phosphokinase, and 100 mM Tris,
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Table 1. Tissue solute content (mOsm/kg H20) in the kidneys of
normocalcemic (N = 7) and hypercalcemic rats (N = 7)
Normocalcemic Hypercalcemic
Cortex
Non-urea solutes 370 11 361 14
P value NS
Total solutes 401 7 396 12
P value NS
Outer medulla
Non-urea solutes 502 29 391 23
P value <0.025
Total solutes 623 39 488 47
P value <0.05
Inner medulla
Non-urea solutes 618 58 421 46
P value <0.025
Total solutes 1119 79 887 70
P value <0.05
pH 7.4, with or without addition of AVP (l0 to iO— M) or
glucagon (I0_6 M). The medium osmolality was increased to 800
mOsm/kg H20 by addition of NaC1 and urea. The reaction
mixture was sealed between two vaseline—coated concave
slides and immersed in a water bath. The reaction was stopped
by addition of cold 150 d stopping solution (3.3 mri ATP, 5 mM
cAMP, 50 mri Tris HC1, pH 7.6, and 3H-cAMP containing 1 x
io cpmlsample to determine recovery). Produced 32P-cAMP
was separated according to the method of Salomon [23] using
Dowex-50-X4 (BioRad, Richmond, California, USA) and alu-
minum oxide (Woelm Pharma, Germany) columns. Assays on
normocalcemic and hypercalcemic rats were analyzed together,
and four to six samples were analyzed for each point of
adenylate cyclase activity. The variation between replication
ranged between 1.3 and 15.6%. Enzyme activity was expressed
as fmoles cAMP produced/mm/30 mm. The four to six deter-
minations in any given experiment were meaned for an "n" of
one.
cAMP phosphodiesterase activity. The effect of hypercalce-
mia on the activity of cAMP phosphodiesterase was studied.
Following microdissection the fluid was aspirated off, 0.5 p1
hypoosmotic medium (1 m MgC12, 0.25 mrs'i EDTA, 0.1%
bovine serum albumin, and 1 mrvi Tris, pH 7.4) was added under
the microscope; the samples were then immediately frozen by
placing them on a block of dry ice. The frozen tubules were
thawed once and refrozen, then kept at —80°C until assayed.
The activity of phosphodiesterase has been found to remain
stable at —80°C for at least five days. cAMP phosphodiesterase
was assayed in a two step reaction [211. The first reaction was
performed in a buffer containing 10 mri MgSO4, 0.1 mrvi EDTA,
50 mM Tris, pH 8.0, and 1 x 106 M 3H-cAMP (4 X i05 cpm/5j.d, New England Nuclear) as a substrate. The reaction was
carried out for 20 minutes at 37°C and the second reaction was
performed with 1 mg/mi 5'-nucleotidase [snake venom (naja
naja), Caibiochem—Behring Corp., La jolla, California, USA]
for 10 minutes at 37°C. The produced 3H-adenosine was sepa-
rated chromatographically using QAE-Sephadex A-25 (Pharm-
acia, Piscataway, New Jersey, USA) and counted. All of the
assays were performed in four to six replicate. The variation
between replication was less than 5%. The results of the four to
six replicates were meaned for an "n" of one.
Table 2. Protein content in dissected segments of the outer medullary
collecting ducts (OMCD), inner medullary collecting ducts (IMCT)






OMCD (N = 4) 0.111 0.013 0.103 0.0092
P value NS
IMCD (N = 4) 0.108 0.010 0.116 0.012
P value NS
MAL (N = 5) 0.097 0.013 0.099 0.0095
P value NS
N reflects the number of paired rats in each group. Six to eight
tubules were studied in each rat.
Determination of protein. In order to ascertain whether
hypercalcemia causes an alteration in the protein content/mm
tubule, the protein content of microdissected, measured tubules
was determined by the method of Lowry et al [24] after 0.5 p1
of 0.1% SDS was added to the tubules.
Comparisons between normocalcemic and hypercalcemic
rats were performed by the unpaired Student's i-test. A P value
of less then 0.05 was considered significant. The data is pre-
sented as the standard error of the mean. This SEM was
obtained from the mean of number of animals and not all the
individual samples.
Results
The seven rats placed on a vitamin D supplemented diet had
a mean serum calcium of 12.6 0.4 mg% after six to seven days
on the diet as compared to 9.8 0.3 mg% of their seven pair fed
and pair watered controls (P < 0.001). The maximal urinary
osmolality was 2478 93 mOsmlkg H2O in controls and 1982
119 mOsm/kg H20 in the hypercalcemic rats (P < 0.01). Table
1 summarizes the effect of the hypercalcemia on tissue content.
The percent water content was not different in the kidneys of
normocalcemic and hypercalcemic rats. The cortical content of
solute was not different in the two groups of animals. However,
the total tissue solute content was lower both in the outer
medulla, and as we noted previously [5], in the inner medulla as
well (P < 0.05). It is of note that this difference in solute content
was entirely accounted for by non-urea solutes (2 + [Na + K])
as the content of urea was comparable in the two groups of
animals. More specificially, the increment was in Na rather than
K.
In vitro studies
The gross appearance of the tubules obtained from normo-
calcemic and hypercalcemic rats was not different. As is noted
in Table 2, the protein/mm length was not significantly different
between normocalcemic and hypercalcemic rats in any of the
three nephron segments under study. The data are presented
herein relative to tubular length.
Studies in the medullary collecting ducts. Our initial studies
were directed to assess whether the OMCD of hypercalcemic
rats has an impairment in adenylate cyclase response to vaso-
pressin. As is depicted in the Figure 1A, in five pairs of
normocalcemic and hypercalcemic rats the activity of the
enzyme obtained from the two groups of animals was essen-
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Basal l0 M AVP
OMCD fmoleslmm
Media osmolality 300 (N = 5)
Normocalcemic 7.43 2.8 22.1 1.4
Hypercalcemia 5.32 1.5 29.1 3.6
P value NS NS
Media osmolality 800 (N = 6)
Normocalcemic 10.3 2.6 35.1 5.7
Hypercalcemia 8.57 1.1 29.1 6.3
P value NS NS
IMCD fmoles/mm
Media osmolality 300 (N = 5)
Normocalcemic 8.02 3.0 32.1 3.6
Hypercalcemia 8.61 1.2 26.2 4.0
P value NS NS
Media osmolality 2000 (N = 7)
Normocalcemic 8.57 1.1 138.0 10.1
Hypercalcemia 9.75 3.1 165.0 15.7
P value NS NS
was 16.2 1.3 fm/mm/mm in normocalcemic rats and 14.9
0.9 fmlmin/mm in hypercalcemic rats (N = 4). Likewise, in the
IMCD the activities were 11.6 0.89 and 12.3 1.1 fm/mm/mm
in normocalcemic and hypercalcemic rats, respectively (N =5).
While the above results would suggest an intact ability to
accumulate cAMP in the collecting ducts of hypercalcemic rats,
the results obtained with these assays in permeabilized tissues
do not always correlate with in situ cAMP accumulation [20].
We therefore measured cAMP in intact tubule in response to
vasopressin at 300 and 800 mOsm/kg H20 in the OMCD and at
300 and 2000 mOsm/kg H20 in IMCD. The results of those
experiments are summarized in Table 3. Neither the basal nor
the AVP stimulated accumulation of cAMP was significantly
different when tissue from normocalcemic and hypercalcemic
were compared in either of these two AVP-responsive nephron
segments in isotonic and hypertonic media conditions.
Studies in medullary thick ascending limb. The response of in
situ intact MAL to l0— M AVP in normocalcemic and hyper-
calcemic rats is shown in Table 4. Despite the fact that the basal
activities in the tissue of hypercalcemic rats was somewhat
higher, the tissue seemed to be essentially unresponsive to AVP
as the measured cAMP was barely, and not significantly higher
after the hormones. In contrast, the tissues of the normocalce-
mic rats sustained a small but consistent increase in cAMP, an
increase that was significantly (P < 0.01) greater than that of
experimental rats.
To assess whether the failure to accumulate cAMP in the
MAL of hypercalcemic rats is due to a defect in the generation
of the nucleotide, we measured the adenylate cyclase in these
tubules from six pairs of rats. Since we find consistent re-
sponses only at l0- M AVP, this concentration of hormone was
employed. Table 5 shows the activities in the six experiments.
Both normocalcemic and hypercalcemic rats had significant
increases in adenylate cyclase activity in response to AVP.
However, the increase in hypercalcemic rats was modest and
significantly (P < 0.02) lower than that of normocalcemic
Table 3. Accumulation of cAMP in the outer medullary collecting
ducts (OMCD) and inner medullary collecting ducts (IMCD) of
normocalcemic and hypercalcemic rats
o io 10-8
[AVP], M N denotes the number of paired experiments in each group. Four to
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Fig. 1. Effect of chronic hypercalcemia on the activity of adenylate
cyclase at 800 mOsm/kg If2O in outer medullary collecting ducts
(OMCD) (A) and inner medullary collecting ducts (IMCD) (B). At no
concentration of vasopressin was the activity different in the two groups
of rats.
tially indistinguishable at concentrations of vasopressin of l0—,
l0_ and l0- M. Since we recently noted divergent responses
to vasopressin in OMCD and IMCD of hypokalemic rats [19] we
determined the activity of adenylate cyclase in dissected
IMCD. As noted in Figure 1B, again the response in six pairs of
normocalcemic and hypercalcemic rats was indistinguishable.
Likewise the activity of cAMP-phosphodiesterase studied at a
substrate concentration of l06 M was not found to be different.
Specifically, the cAMP-phosphodiesterase activity in OMCD
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Table 4. Accumulation of cAMP in medullary ascending limb (MAL)
of normocalcemic and hypercalcemic rats in response to lO M AVP
Basal M AVP
cAMP fmoles/mm
Media osmolality 300 (N = 5)
Normocalcemic 2.1 0.3 12.1 1.7
Hypercalcemia 3.5 1.1 6.4 1.4
P value NS <0.05
Media osmolality 800 (N = 4)
Normocalcemic 1.6 0.3 16.8 2.3
Hypercalcemia 2.6 1.0 4.0 2.1
P value NS <0.01
N denotes the number of paired rats studied. In each case four to six
tubules were measured.
controls. To assess whether an increase in cAMP-phosphodi-
esterase activity could also contribute to the unpaired cAMP
accumulation in the MAL we measured the activity of the
enzyme in four pairs of rats. This was comparable in the tissue
of the two groups (12.31 3.8 in normocalceinic vs. 10.6 3.1
fmoles/min/mm in hypercalcemic).
In order to ascertain whether the impairment in MAL ade-
nylate cyclase is specific to AVP, the response of this segment
to glucagon (10—6 M) was assessed. Adenylate cyclase increased
from 15.48 3.1 to 229.2 26.6 fmlmm/30 mm in normocal-
cemic rats (N = 6), but only from 16.22 2.99 to 144.2 22.8
fmlmm/30 mm in the MAL of hypercalcemic rats (N = 6). The
response was significantly attenuated in the hypercalcemic rats
(P < 0.05).
Discussion
A disturbance in renal concentration in hypercalcemia is well
recognized. In the present study we undertook to examine the
cAMP system in isolated nephron segments of the chronically
hypercalcemic rat. Although the biochemical response of renal
tissue has been previously measured [12, 13], these determina-
tions in whole medullary tissue homogenate included cells from
various segments with different vasopressin responsiveness
[14]. More recent studies in which the calcium ion concentra-
tions of the media was acutely changed in isolated tubular
segments have yielded conflicting results [16, 17]. Some of the
conflict may relate to the difference in species used as well as to
the absence or presence of phosphodiesterase inhibitors. In the
present study we systematically analyzed the various compo-
nents of the cAMP system in animals who had a well—estab-
lished concentrating defect. The degree of the concentrating
defect in these rats is not as marked as that encountered when
they are allowed ad libitum water intake [5]. However, we
chose to pair water in order to prevent the marked polyuria and
polydipsia that accompanies hypercalcemia, because these de-
rangements in water turnover can themselves affect the adenyl-
ate cyclase system [25, 26]. The pair watering maneuver thus
allowed to examine the effects of hypercalcemia without the
other confounding variables. Our initial observations were
directed to the medullary collecting duct, a nephron segment
where vasopressin profoundly affects water permeability. In the
chronically hypercalcemic rat neither cAMP accumulation nor
adenylate cyclase activity was affected. This was the case both
at isotonic and hypertonic conditions. Since we have found that
at least in hypokalemia the OMCD and IMCD are not equally
afflicted, we assessed the cAMP in IMCD. Unlike the observa-
tions we recently made in the hypokalemic rat [19], we found no
defect in this nephron segment of the hypercalcemic rat. As was
the case in the OMCD, neither cAMP accumulation nor ade-
nylate cyclase activity was affected at either isotonic or hyper-
tonic media conditions. In summary, therefore, our results
provide no evidence for a derangement in cAMP metabolism in
the collecting ducts of these animals with a well—defined
nephrogenic concentrating defect.
Hypercalcemia has been noted to be associated with a
decrease in tissue solute [6], an observation we substantiated to
be applicable to the inner medulla [5] and in this study the outer
medulla as well. It is of note that this decrement in solutes is
primarily due to non-urea solutes (primarily sodium) rather than
to urea. Since vasopressin appears to be involved in the
resorption of solutes in vasopressin as the MAL [27], the next
experiments were directed to this segment of the nephron. The
accumulation of cAMP both at 300 and 800 mOsm/kg H2O was
impaired in this segment in response to i0 M AVP. An
analysis of the enzymes involved in the generation and break-
down of the nucleotide revealed a decrement in adenylate
cyclase but not a change in cAMP-phosphodiesterase. It would
appear therefore that the nucleotide generation is impaired in
hypercalcemia. Since AVP levels are somewhat higher (12.2
3.6 pg/mI, N = 6) in hypercalcemic rats than in normocalcemic
controls (8.8 1.6 pg/ml, N = 6), the possibility that the
response is decreased because levels of vasopressin are higher
in hypercalcemia, thereby causing a down—regulation of the
receptor should be considered. This possibility, however, ap-
pears remote since it would not be expected to be limited to
only one of the three nephron segments under investigation. In
order to ascertain whether the observed impairment in AVP
responsiveness is specific to this hormone we tested the effects
of 10-6 M glucagon. The response to this hormone was also
impaired reflecting, not surprisingly, a more generalized as-
cending limb dysfunction. Since other hormones that act on the
ascending limb can also influence urinary concentrating ability
the defective response to glucagon may contribute to the defect
as well [28].
The relevance of our observations made in vitamin D-treated
rats to the concentrating defect in hypercalcemia in general and
in man in particular is deserving of comment. Our results reveal
that the collecting duct of the hypercalcemic rat has no abnor-
mality in cAMP metabolism. This is in concert with our studies
in cultured, renal collecting-duct cells which also failed to show
an impairment in cAMP accumulation at extracellular calcium
concentrations as high as 4 m unless cellular calcium also
increased [29]. This may well explain the interesting observa-
tions of Marx et al who noted that patients with hyperealcemia
due to familial hypocalciuric hypercalcemia do not have a
concentrating defect while those with primary hyperpara-
thyroidism do [30]. Only in the presence of a calcium ionophore
(in this case parathyroid hormone) is the system deranged. The
ionophoric effect of PTH in the kidney has not been fully
documented. However, the hormone increases cytosolic cal-
cium in proximal tubular cells [31] and enhances 45Ca uptake in
a vasopressin sensitive epithelium [32]. Since the vitamin
D-treated rat most likely has suppressed levels of PTH, this
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Table 5. Activity of adenylate cyclase in MAL of hypercalcemic and normocalcemic rats (fm/mm/30 mm)
Hypercalcemic Normocalcemic
Experiment Basal 10 M AVP Basal i0 M AVP
1 16.6 1.1(5)a 38.6 2.3(4) 19.3 1.6(4) 54.4 4.2(4)
2 18.8 0.9(4) 19.5 1.6(5) 15.6 1.9(5) 38.2 3.1(4)
3 2,5 0.2(5) 9.6 1.1(6) 5.4 0.6(5) 25.1 1.6(6)
4 7.2 0.6(4) 14.3 1.3(5) 10.0 1.3(6) 34.6 2.0(4)
5 10.9 1.4(6) 28.8 1.2(5) 19.1 1.8(4) 54.2 3.9(5)
6 16.3 2.0(4) 20.3 1.8(4) 8.6 1.4(5) 41.4 3.2(5)
Mean 12.05 21.85 13.00 41.32C
SEMb 2.58 4.25 2.38 4.67
P value <0.05 <0.001
a Denotes SEM number of samples is noted in parenthesis
b SEM obtained from the number of experiments, not the number of samples
P < 0.02 when compared to activity of MAL from hypercalcemic rats
may well explain the failure to observe a biochemical effect on
the cyclase system in the model.
The defect in ascending limb solute—reabsorption described
in hypercalcemia [81 coupled with the biochemical defect noted
in the present studies may well explain the decrement in
non-urea solutes and particularly sodium in the medulla of these
animals. This decrement in tissue solutes could in itself explain
the observed concentrating defect. However, it is not clear
whether these mechanisms can be extrapolated to other species
in which hypercalcemia causes a concentrating defect, such as
the dog and man. Ruggles et al [33] have found no effect of AVP
to increase adenylate cyciase in dog or in human kidneys [33,
34]. The possibility that the decrement in glucagon mediated
cyclase could alter urinary concentration in this species needs
to be considered [28], as deRouffignac et al have demonstrated
in hormone deficient models that hormones other than vaso-
pressin contribute to urinary concentration. It must be ac-
knowledged that our studies by no means exclude the possibil-
ity that hypercalcemia could exert an effect on the collecting
duct whereby its water permeability response to AVP is de-
creased by altering a biochemical step distal to or entirely
independent of cAMP formation. One would have to postulate
that such an effect may be operant in species in which the
medullary ascending limb is not vasopressin sensitive. The
nature of these cAMP effects of hypercalcemia in the collecting
duct should be the focus of future investigators.
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